CITY AstraZeneca/logo 2...AstraZeneca's new logo on the main pro

AstraZeneca Is Selling Its Antibiotics Business to Pfizer

The deal could fetch more than $1.5 billion.

Pharmaceutical company AstraZeneca AZNCF -1.41% said it had agreed to sell its small molecule antibiotics business to Pfizer PFE -0.23% in a deal that could reach more than $1.5 billion.

The portfolio includes approved antibiotics Merrem, Zinforo and Zavicefta, and ATM-AVI and CXL, which are in clinical development, it said.

Pfizer will pay $550 million upon completion and a further unconditional $175 million in January 2019, AstraZeneca said, plus up to $250 million in milestones, up to $600 million in sales-related payments and recurring, double-digit royalties on future sales of Zavicefta and ATM-AVI in certain markets.


The British company said the agreement did not impact its financial guidance for 2016.

Source: Fortune

Posted by:  The Wealthy Doctor

Permalink: http://wealthy-doctor.com/astrazeneca-is-selling-its-antibiotics-business-to-pfizer/

 

AstraZeneca Is Selling Its Antibiotics Business to Pfizer - overview

Summary: The deal could fetch more than $1.5 billion.
Pharmaceutical company AstraZeneca AZNCF -1.41% said it had agreed to sell its small molecule antibiotics business to Pfizer PFE -0.23% in a deal that could reach more than $1.5 billion.

The portfolio includes approved antibiotics Merrem, Zinforo and Zavicefta, and ATM-AVI and CXL, which are in clinical development, it said.

Pfizer will pay $550 million upon completion and a further unconditional $175 million in January 2019, AstraZeneca said, plus up to $250 million in milestones, up to $600 million in sales-related payments and recurring, double-digit royalties on future sales of Zavicefta and ATM-AVI in certain markets.

Share this article: